Search

everythinglearnresearchcommunity

for

Search:↓

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

The document concludes that misdiagnosis in skin conditions is common, certain treatments can cause allergic reactions, and some skin symptoms are linked to leukemia, especially in certain Japanese regions.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Skin issues can indicate immune system problems.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Current treatments for alopecia show no significant long-term benefits.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Male faces age with more wrinkles and hair loss, influenced by both body changes and environmental factors.

Reflectance confocal microscopy can tell apart white dots on the scalp as either sweat gland ducts or hair follicle openings.

Cyclosporine A was found to increase hair growth in mouse whisker follicles.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

Ciclosporin might be a good alternative treatment for certain hearing loss that responds to steroids.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Most skin tumors in the study were benign, with squamous cell carcinoma being the most common malignant type.

Ketoconazole's structure and dynamics are linked, aiding antifungal drug development.

A woman experienced excessive hair growth after using a hair loss treatment with minoxidil.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.